COMP <GO>
A vs JNJ // GROSS PROFIT MARGIN
Agilent Technologies Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: A 5
— JNJ 10
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $174.87 (-3.47%) • MKT CAP: $51.07B
gross-margins
52.40%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (A VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | A | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 52.40% | 67.90% | -15.50 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.30% | 25.50% | -10.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.4x | 18.5x | +9.90 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 2.26% | 2.97% | -0.71 | JNJ | /fcf-yield <GO> |
| Operating Margin | 21.30% | 34.70% | -13.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 18.80% | 28.50% | -9.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 6.00% | +0.70 | A | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.55% | 0.00% | +0.55 | A | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.50 | 5.59 | +0.91 | A | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | A | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.20% | -0.60 | A | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 60.4 | -5.44 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.08 | -0.17 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.5x | 23.0x | +13.50 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $51.07B | $662.49B | -$611.42B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | A REV | JNJ REV | A GROSS % | JNJ GROSS % | A FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.95B | $94.19B | 52.4% | 67.9% | $1.15B | $19.70B |
| FY 2024 | $6.51B | $88.82B | 54.3% | 69.1% | $1.37B | $19.84B |
| FY 2023 | $6.83B | $85.16B | 44.0% | 44.0% | $1.46B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
A // BETA 0.91
JNJ // BETA 1.08